614 results on '"Gao, Qinglei"'
Search Results
2. SOCS3 inhibiting JAK-STAT pathway enhances oncolytic adenovirus efficacy by potentiating viral replication and T-cell activation
3. New insights into the stemness of adoptively transferred T cells by γc family cytokines
4. Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis
5. Timing of interval debulking surgery and postoperative chemotherapy after neoadjuvant chemotherapy in advanced epithelial ovarian cancer: a multicenter real-world study
6. Development and validation of a nomogram to predict cancer-specific survival of mucinous epithelial ovarian cancer after cytoreductive surgery
7. A ribosomal gene panel predicting a novel synthetic lethality in non-BRCAness tumors
8. Inhibition of SF3B1 improves the immune microenvironment through pyroptosis and synergizes with αPDL1 in ovarian cancer
9. CAR-T therapy and targeted treatments: Emerging combination strategies in solid tumors
10. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study
11. Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study
12. Adjuvant chemotherapy versus adjuvant concurrent chemoradiotherapy after radical surgery for early-stage cervical cancer: a randomized, non-inferiority, multicenter trial
13. Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors
14. Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer
15. Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies
16. Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects
17. Prognostic significance of positive peritoneal cytology in endometrial carcinoma based on ESGO/ESTRO/ESP risk classification: A multicenter retrospective study
18. PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities
19. Biomarker-driven targeted therapy in patients with recurrent platinum-resistant epithelial ovarian cancer (BRIGHT): protocol for an open-label, multicenter, umbrella study
20. Deep learning-enabled pelvic ultrasound images for accurate diagnosis of ovarian cancer in China: a retrospective, multicentre, diagnostic study
21. Enhancing oncolytic virus efficiency with methionine and N-(3-aminoprolil)methacrylamide modified acrylamide cationic block polymer
22. EP330/#1472 Artificial intelligence-based model enables accurate diagnosis of ovarian cancer using laboratory tests: a multicenter, retrospective study
23. C/EBPβ promotes poly(ADP-ribose) polymerase inhibitor resistance by enhancing homologous recombination repair in high-grade serous ovarian cancer
24. Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review
25. Semaphorin 4C accelerates disease progression and enables disease detection in breast cancer
26. Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study
27. Discrepancies in Genetic Testing Procedures of BRCA1/2 Mutations: A National Survey Across China
28. Development and validation of an online model to predict critical COVID-19 with immune-inflammatory parameters
29. PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer
30. TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA/ROCK pathway
31. Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta‐analysis
32. Neoadjuvant chemotherapy-related platinum resistance in ovarian cancer
33. Hyperbranched poly(β-amino ester) based polyplex nanopaticles for delivery of CRISPR/Cas9 system and treatment of HPV infection associated cervical cancer
34. Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
35. RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer
36. MCP-1/CCR-2 axis in adipocytes and cancer cell respectively facilitates ovarian cancer peritoneal metastasis
37. Integrated analysis identifies RAC3 as an immune‐related prognostic biomarker associated with chemotherapy sensitivity in endometrial cancer
38. Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer
39. Expression of PAWR predicts prognosis of ovarian cancer
40. Synergistic effect of TRAIL and irradiation in elimination of glioblastoma stem-like cells
41. Correction to: Discrepancies in Genetic Testing Procedures of BRCA1/2 Mutations: A National Survey Across China
42. Abstract CT079: Efficacy and safety of sintilimab (anti-PD-1 mAb) for advanced cervical cancer: Results from a Phase II trial
43. Supplementary Figure legends from Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB–Triggered SASP in Cancer-Associated Fibroblasts
44. Figure S3 from Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB–Triggered SASP in Cancer-Associated Fibroblasts
45. Table S1-S6 from Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB–Triggered SASP in Cancer-Associated Fibroblasts
46. Data from Bepotastine Sensitizes Ovarian Cancer to PARP Inhibitors through Suppressing NF-κB–Triggered SASP in Cancer-Associated Fibroblasts
47. Figure S4 from Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer
48. Supplementary Figures and Legends from Semaphorin 4C Promotes Macrophage Recruitment and Angiogenesis in Breast Cancer
49. Table S1-S4 from Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer
50. Supplementary figure legends from Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.